Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades
Cellebrite shares surged 24% to $19.80 on November 13 after reporting third-quarter revenue of $126 million, up 18% year-over-year, and raising its 2025 outlook. The company posted non-GAAP net income of $36.9 million and boosted guidance for both Q4 and the full year, prompting bullish analyst calls.
